PM Announcement That Prescription Charge Exemptions Will Be Extended - NPA Reaction
Main Category: Cancer / OncologyAlso Included In: Pharmacy / Pharmacist
Article Date: 25 Sep 2008 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Commenting on the Prime Minister's announcement at the Labour Party conference about extending prescription charge exemptions to people with cancer in April 2009 and eventually to all people with long term conditions, John Turk, Chief Executive of the National Pharmacy Association said:
"The NPA has long called for a review of prescription charges and we are pleased to see this is now underway. The current arrangements are inequitable and inconsistent, and we hope that a fairer system will arise from the Prime Minister's commitment to reform.
It will be important that any subsequent increases in prescription volume are factored in to the ongoing discussions between pharmacy and Government.
We welcome the Prime Minister's focus on improving the value from prescribed medicines. Services such as Medicines Use Review and repeat dispensing are tried and tested ways of getting the most out of medicines.
There are many other ways to offset the cost of any changes. In particular, I was pleased to hear the Prime Minister reaffirm in the same speech his commitment to the vascular risk management programme where real and sustainable savings may be obtained - through preventing illness and the associated human and financial costs. The NPA will play a major part in gearing up community pharmacy for a central role in this programme."
Notes
During the annual Labour party conference, the Prime Minister Gordon Brown announced that from April 2009 cancer patients will be exempted from needing to pay the prescription charge and that there will be a gradual phasing out of prescription charges for all patients who are suffering from a long-term medical condition.
No definite timetable was scheduled for when other long-term clinical conditions would be exempted and the applicable long-term clinical conditions are still subject to consultation.
National Pharmacy Association
Visit our cancer / oncology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/122989.php>
APA
http://www.medicalnewstoday.com/releases/122989.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




